These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2193994)

  • 1. Development of D-timolol for the treatment of glaucoma and ocular hypertension.
    Chiou GC
    J Ocul Pharmacol; 1990; 6(1):67-74. PubMed ID: 2193994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of D-timolol on intraocular pressure (IOP), beta blocking activity, and the dynamic changes of drug concentrations in aqueous humor.
    Zhao F; Ji XC; Zheng YZ
    J Ocul Pharmacol; 1989; 5(4):271-9. PubMed ID: 2576432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ocular hypertension and glaucoma with dopamine antagonists.
    Chiou GC
    Ophthalmic Res; 1984; 16(3):129-34. PubMed ID: 6147806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of d-timolol on intraocular pressure in patients with ocular hypertension.
    Keates EU; Stone R
    Am J Ophthalmol; 1984 Jul; 98(1):73-8. PubMed ID: 6742081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R-enantiomer of timolol: a potential selective ocular antihypertensive agent.
    Share NN; Lotti VJ; Gautheron P; Schmitt C; Gross DM; Hall RA; Stone CA
    Graefes Arch Clin Exp Ophthalmol; 1984; 221(5):234-8. PubMed ID: 6092239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaninolol: a novel compound for the treatment of glaucoma and ischemic retinopathy.
    Wu BN; Hong SJ; Sheu MM; Chen IJ; Liu SX; Chiou GC
    J Ocul Pharmacol Ther; 1995; 11(3):213-20. PubMed ID: 8590252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative multiple-dose intraocular pressure responses of nadolol and timolol in glaucoma and ocular hypertension.
    Krieglstein GK; Mohamed J
    Acta Ophthalmol (Copenh); 1982 Apr; 60(2):284-92. PubMed ID: 6127861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timolol increased retrobulbar flow velocities in untreated glaucoma eyes but not in ocular hypertension.
    Bergstrand IC; Heijl A; Wollmer P; Hansen F; Harris A
    Acta Ophthalmol Scand; 2001 Oct; 79(5):455-61. PubMed ID: 11594978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects.
    Huang SF; Chen JL; Yeh MK; Chiang CH
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):445-53. PubMed ID: 16386086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
    Nordmann JP; Söderström M; Rouland JF; Malecaze F
    Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
    Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
    PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
    Camras CB
    Ophthalmology; 1996 Jan; 103(1):138-47. PubMed ID: 8628544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of D- and L-isomers of timolol on retinal and choroidal blood flow in ocular hypertensive rabbit eyes.
    Chiou GC; Chen YJ
    J Ocul Pharmacol; 1992; 8(3):183-90. PubMed ID: 1453082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-masked randomized crossover study comparing the effect of latanoprost/timolol and brimonidine/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension.
    Hommer A; Sperl P; Resch H; Popa-Cherecheanu A; Qiao C; Schmetterer L; Garhöfer G
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):569-75. PubMed ID: 22775229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: year-three results. Brimonidine Study Group II.
    Melamed S; David R
    Clin Ther; 2000 Jan; 22(1):103-11. PubMed ID: 10688394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.
    LeBlanc RP
    Ophthalmology; 1998 Oct; 105(10):1960-7. PubMed ID: 9787370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.
    Mishima HK; Masuda K; Kitazawa Y; Azuma I; Araie M
    Arch Ophthalmol; 1996 Aug; 114(8):929-32. PubMed ID: 8694726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.
    Zimmerman TJ; Kaufman HE
    Arch Ophthalmol; 1977 Apr; 95(4):601-4. PubMed ID: 322648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.